GeneralBullishBlockonomi · Jun 76/10
📰
Pfizer (PFE) Stock Gains Ground on Once-Monthly Obesity Drug Breakthrough
Pfizer stock rose 1.36% following positive clinical data for its once-monthly obesity treatment, which demonstrated 15% weight loss in trials. The pharmaceutical company also announced a $10.5 billion cancer acquisition and advanced vaccine development, though patent expirations present ongoing headwinds.
